Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...
Regulus Resources Inc. operates as a mineral exploration company in Canada and Peru. The company’s flagship project is the AntaKori copper-gold-silver project located in the Yanacocha-Hualgayoc mining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback